Clinical Trials Directory

Trials / Completed

CompletedNCT03108365

Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Axio Biosolutions Pvt. Ltd. · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Accepted

Summary

The rationale of this study was to evaluate the efficacy of Axiostat hemostatic dental dressing in achieving hemostasis post-extraction and determining its effect on pain and healing of the extraction wound, compared to control, i.e. conventional method of extraction in patients on oral anti-platelet therapy.

Conditions

Interventions

TypeNameDescription
DEVICEAxiostatAxiostat® is a sterile, non-absorbable haemostatic dressing intended to control profuse bleeding within minutes of application by providing an active mechanical barrier to the wound site. Axiostat® stops moderate to severe bleeding due to cuts, abrasions, lacerations, venous/arterial punctures and more. Mechanism of action is such that Axiostat® is an extremely positive dressing that becomes very sticky in the presence of negatively charged blood and thus seals the wound area.
DEVICECotton GauzeSize: 1 x 1 cm

Timeline

Start date
2014-12-19
Primary completion
2016-03-24
Completion
2016-03-24
First posted
2017-04-11
Last updated
2019-07-05

Source: ClinicalTrials.gov record NCT03108365. Inclusion in this directory is not an endorsement.

Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Heali (NCT03108365) · Clinical Trials Directory